In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs.

Of the drugs that had Z ≥ 2 at any given site, a decreasing trend was observed in the number of predicted sites bound with respect to frequency of drugs; 5 sites were chosen as the cutoff point.

also in 47,180 other papers